Cargando…
Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
The RUNX3 gene is regarded as a tumor suppressor gene in many human solid tumors, and its inactivation is believed to be related with solid tumor carcinogenesis. As little information is available about the role of the RUNX3 gene in breast cancer, we investigated the relationship between the RUNX3 g...
Autores principales: | Hwang, Ki-Tae, Han, Wonshik, Bae, Ji-Yeon, Hwang, Sung Eun, Shin, Hyuk Jai, Lee, Jeong Eon, Kim, Sung-Won, Min, Hyun Jung, Noh, Dong-Young |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694388/ https://www.ncbi.nlm.nih.gov/pubmed/17923751 http://dx.doi.org/10.3346/jkms.2007.22.S.S24 |
Ejemplares similares
-
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
por: Han, Wonshik, et al.
Publicado: (2006) -
Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer
por: Lee, Jeong Eon, et al.
Publicado: (2005) -
A catalog of hemizygous variation in 127 22q11 deletion patients
por: Hestand, Matthew S, et al.
Publicado: (2016) -
Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021) -
Hemizygous deletion in the OTC gene results in ornithine transcarbamylase deficiency: A case report
por: Wang, Li-Ping, et al.
Publicado: (2022)